The use of myocytes as a model for developing successful heart preservation solutions

Thomas Schmid, Gregory Landry, Barry L. Fields, F. O. Belzer, R. A. Haworth, James H. Southard

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The development of a successful method to preserve the heart for relatively long periods (24-48 hr) requires demonstrating successful orthotopic transplantation and long-term survival after preservation. There are, however, multiple variables that may affect the quality of heart preservation, and it is nearly Impossible to sYlltematically study all the variables in this complicated model. One model that may be useful to study how preservation parameters affect heart cell preservation is the isolated myocyte preparation. In this study myocytes were isolated from the rabbit heart and the effects of up to 24 hr cold storage on viability measured to determine if this would be a suitable preservation model. Myocytes were stored in various preservation solutions including; EuroCollins (EC), two cardiopleglc solutions (Stanford[ST] and Bretschneider solution [HTK] and the University of Wisconsin solution (UW) with or without the addition of polyethylene glycol. The viability of myocytes was judged by measuring the effects of preservation and rewarming after preservation on cellular morphology (percent rod-shaped cells), ATP concentration, and LDU release. Myocytes preserved in the cardioplegic solutions were least well preserved after 12 and 24 hr storage, as judged by the loss of rod-shaped morphology and lower ATP concentration. Preservation in EC resulted in a decrease in the percent rod-shaped cells after 12 hr and 24 hr storage that was greater than obtained in the UW solutions. The best preservation of myocyte morphology and highest content of ATP was obtained in myocytes stored in the UW solutions. Especially those containing PEG. The myocyte model of heart preservation shows a loss of cell integrity that is related to the preservation solution (HTK > ST > EC > UWPEG) and these results are similar to what has been shown in the past with other models of heart preservation. Thus the myocyte model appears to be a useful method to test how many preservation solutions and preservation variables affect heart cell metabolism. In the future. results from these types of studies may find use in developing improved heart preservation solutions for testing in the orthotopic transplant model.

Original languageEnglish (US)
Pages (from-to)20-26
Number of pages7
JournalTransplantation
Volume52
Issue number1
StatePublished - 1991
Externally publishedYes

Fingerprint

Muscle Cells
Adenosine Triphosphate
Cardioplegic Solutions
Rewarming
Transplantation
Rabbits
Transplants

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Schmid, T., Landry, G., Fields, B. L., Belzer, F. O., Haworth, R. A., & Southard, J. H. (1991). The use of myocytes as a model for developing successful heart preservation solutions. Transplantation, 52(1), 20-26.

The use of myocytes as a model for developing successful heart preservation solutions. / Schmid, Thomas; Landry, Gregory; Fields, Barry L.; Belzer, F. O.; Haworth, R. A.; Southard, James H.

In: Transplantation, Vol. 52, No. 1, 1991, p. 20-26.

Research output: Contribution to journalArticle

Schmid, T, Landry, G, Fields, BL, Belzer, FO, Haworth, RA & Southard, JH 1991, 'The use of myocytes as a model for developing successful heart preservation solutions', Transplantation, vol. 52, no. 1, pp. 20-26.
Schmid T, Landry G, Fields BL, Belzer FO, Haworth RA, Southard JH. The use of myocytes as a model for developing successful heart preservation solutions. Transplantation. 1991;52(1):20-26.
Schmid, Thomas ; Landry, Gregory ; Fields, Barry L. ; Belzer, F. O. ; Haworth, R. A. ; Southard, James H. / The use of myocytes as a model for developing successful heart preservation solutions. In: Transplantation. 1991 ; Vol. 52, No. 1. pp. 20-26.
@article{22a78b1cc1934f43bff5f3aa42a348ce,
title = "The use of myocytes as a model for developing successful heart preservation solutions",
abstract = "The development of a successful method to preserve the heart for relatively long periods (24-48 hr) requires demonstrating successful orthotopic transplantation and long-term survival after preservation. There are, however, multiple variables that may affect the quality of heart preservation, and it is nearly Impossible to sYlltematically study all the variables in this complicated model. One model that may be useful to study how preservation parameters affect heart cell preservation is the isolated myocyte preparation. In this study myocytes were isolated from the rabbit heart and the effects of up to 24 hr cold storage on viability measured to determine if this would be a suitable preservation model. Myocytes were stored in various preservation solutions including; EuroCollins (EC), two cardiopleglc solutions (Stanford[ST] and Bretschneider solution [HTK] and the University of Wisconsin solution (UW) with or without the addition of polyethylene glycol. The viability of myocytes was judged by measuring the effects of preservation and rewarming after preservation on cellular morphology (percent rod-shaped cells), ATP concentration, and LDU release. Myocytes preserved in the cardioplegic solutions were least well preserved after 12 and 24 hr storage, as judged by the loss of rod-shaped morphology and lower ATP concentration. Preservation in EC resulted in a decrease in the percent rod-shaped cells after 12 hr and 24 hr storage that was greater than obtained in the UW solutions. The best preservation of myocyte morphology and highest content of ATP was obtained in myocytes stored in the UW solutions. Especially those containing PEG. The myocyte model of heart preservation shows a loss of cell integrity that is related to the preservation solution (HTK > ST > EC > UWPEG) and these results are similar to what has been shown in the past with other models of heart preservation. Thus the myocyte model appears to be a useful method to test how many preservation solutions and preservation variables affect heart cell metabolism. In the future. results from these types of studies may find use in developing improved heart preservation solutions for testing in the orthotopic transplant model.",
author = "Thomas Schmid and Gregory Landry and Fields, {Barry L.} and Belzer, {F. O.} and Haworth, {R. A.} and Southard, {James H.}",
year = "1991",
language = "English (US)",
volume = "52",
pages = "20--26",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The use of myocytes as a model for developing successful heart preservation solutions

AU - Schmid, Thomas

AU - Landry, Gregory

AU - Fields, Barry L.

AU - Belzer, F. O.

AU - Haworth, R. A.

AU - Southard, James H.

PY - 1991

Y1 - 1991

N2 - The development of a successful method to preserve the heart for relatively long periods (24-48 hr) requires demonstrating successful orthotopic transplantation and long-term survival after preservation. There are, however, multiple variables that may affect the quality of heart preservation, and it is nearly Impossible to sYlltematically study all the variables in this complicated model. One model that may be useful to study how preservation parameters affect heart cell preservation is the isolated myocyte preparation. In this study myocytes were isolated from the rabbit heart and the effects of up to 24 hr cold storage on viability measured to determine if this would be a suitable preservation model. Myocytes were stored in various preservation solutions including; EuroCollins (EC), two cardiopleglc solutions (Stanford[ST] and Bretschneider solution [HTK] and the University of Wisconsin solution (UW) with or without the addition of polyethylene glycol. The viability of myocytes was judged by measuring the effects of preservation and rewarming after preservation on cellular morphology (percent rod-shaped cells), ATP concentration, and LDU release. Myocytes preserved in the cardioplegic solutions were least well preserved after 12 and 24 hr storage, as judged by the loss of rod-shaped morphology and lower ATP concentration. Preservation in EC resulted in a decrease in the percent rod-shaped cells after 12 hr and 24 hr storage that was greater than obtained in the UW solutions. The best preservation of myocyte morphology and highest content of ATP was obtained in myocytes stored in the UW solutions. Especially those containing PEG. The myocyte model of heart preservation shows a loss of cell integrity that is related to the preservation solution (HTK > ST > EC > UWPEG) and these results are similar to what has been shown in the past with other models of heart preservation. Thus the myocyte model appears to be a useful method to test how many preservation solutions and preservation variables affect heart cell metabolism. In the future. results from these types of studies may find use in developing improved heart preservation solutions for testing in the orthotopic transplant model.

AB - The development of a successful method to preserve the heart for relatively long periods (24-48 hr) requires demonstrating successful orthotopic transplantation and long-term survival after preservation. There are, however, multiple variables that may affect the quality of heart preservation, and it is nearly Impossible to sYlltematically study all the variables in this complicated model. One model that may be useful to study how preservation parameters affect heart cell preservation is the isolated myocyte preparation. In this study myocytes were isolated from the rabbit heart and the effects of up to 24 hr cold storage on viability measured to determine if this would be a suitable preservation model. Myocytes were stored in various preservation solutions including; EuroCollins (EC), two cardiopleglc solutions (Stanford[ST] and Bretschneider solution [HTK] and the University of Wisconsin solution (UW) with or without the addition of polyethylene glycol. The viability of myocytes was judged by measuring the effects of preservation and rewarming after preservation on cellular morphology (percent rod-shaped cells), ATP concentration, and LDU release. Myocytes preserved in the cardioplegic solutions were least well preserved after 12 and 24 hr storage, as judged by the loss of rod-shaped morphology and lower ATP concentration. Preservation in EC resulted in a decrease in the percent rod-shaped cells after 12 hr and 24 hr storage that was greater than obtained in the UW solutions. The best preservation of myocyte morphology and highest content of ATP was obtained in myocytes stored in the UW solutions. Especially those containing PEG. The myocyte model of heart preservation shows a loss of cell integrity that is related to the preservation solution (HTK > ST > EC > UWPEG) and these results are similar to what has been shown in the past with other models of heart preservation. Thus the myocyte model appears to be a useful method to test how many preservation solutions and preservation variables affect heart cell metabolism. In the future. results from these types of studies may find use in developing improved heart preservation solutions for testing in the orthotopic transplant model.

UR - http://www.scopus.com/inward/record.url?scp=0025773111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025773111&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 20

EP - 26

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -